Australia · Delayed Price · Currency is AUD Atlas Arteria Statistics
Total Valuation
Atlas Arteria has a market cap or net worth of AUD 7.57 billion. The enterprise value is 8.98 billion.
| Market Cap | 7.57B |
| Enterprise Value | 8.98B |
Important Dates
The last earnings date was Wednesday, August 27, 2025.
| Earnings Date | Aug 27, 2025 |
| Ex-Dividend Date | Mar 25, 2025 |
Share Statistics
Atlas Arteria has 1.45 billion shares outstanding. The number of shares has decreased by -0.73% in one year.
| Current Share Class | 1.45B |
| Shares Outstanding | 1.45B |
| Shares Change (YoY) | -0.73% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 76.02% |
| Float | 1.45B |
Valuation Ratios
The trailing PE ratio is 25.33 and the forward PE ratio is 15.86. Atlas Arteria's PEG ratio is 0.40.
| PE Ratio | 25.33 |
| Forward PE | 15.86 |
| PS Ratio | 49.24 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.89 |
| P/FCF Ratio | 81.43 |
| P/OCF Ratio | 80.40 |
| PEG Ratio | 0.40 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.55, with an EV/FCF ratio of 96.56.
| EV / Earnings | 30.05 |
| EV / Sales | 58.39 |
| EV / EBITDA | 26.55 |
| EV / EBIT | 33.63 |
| EV / FCF | 96.56 |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.28.
| Current Ratio | 2.35 |
| Quick Ratio | 2.26 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 24.18 |
| Debt / FCF | 18.25 |
| Interest Coverage | -0.01 |
Financial Efficiency
Return on equity (ROE) is 3.92% and return on invested capital (ROIC) is -0.01%.
| Return on Equity (ROE) | 3.92% |
| Return on Assets (ROA) | -0.01% |
| Return on Invested Capital (ROIC) | -0.01% |
| Return on Capital Employed (ROCE) | -0.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Atlas Arteria has paid 2.60 million in taxes.
| Income Tax | 2.60M |
| Effective Tax Rate | 1.07% |
Stock Price Statistics
The stock price has increased by +2.96% in the last 52 weeks. The beta is 0.58, so Atlas Arteria's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +2.96% |
| 50-Day Moving Average | 5.21 |
| 200-Day Moving Average | 5.05 |
| Relative Strength Index (RSI) | 44.77 |
| Average Volume (20 Days) | 1,798,578 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Atlas Arteria had revenue of AUD 153.80 million and earned 298.80 million in profits. Earnings per share was 0.21.
| Revenue | 153.80M |
| Gross Profit | 111.80M |
| Operating Income | -1.00M |
| Pretax Income | 242.00M |
| Net Income | 298.80M |
| EBITDA | 70.20M |
| EBIT | -1.00M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 290.40 million in cash and 1.70 billion in debt, giving a net cash position of -1.41 billion or -0.97 per share.
| Cash & Cash Equivalents | 290.40M |
| Total Debt | 1.70B |
| Net Cash | -1.41B |
| Net Cash Per Share | -0.97 |
| Equity (Book Value) | 6.12B |
| Book Value Per Share | 4.22 |
| Working Capital | 173.50M |
Cash Flow
In the last 12 months, operating cash flow was 94.20 million and capital expenditures -1.20 million, giving a free cash flow of 93.00 million.
| Operating Cash Flow | 94.20M |
| Capital Expenditures | -1.20M |
| Free Cash Flow | 93.00M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 72.69%, with operating and profit margins of -0.65% and 194.28%.
| Gross Margin | 72.69% |
| Operating Margin | -0.65% |
| Pretax Margin | 157.35% |
| Profit Margin | 194.28% |
| EBITDA Margin | 45.64% |
| EBIT Margin | -0.65% |
| FCF Margin | 60.47% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 7.66%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 7.66% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 194.24% |
| Buyback Yield | 0.73% |
| Shareholder Yield | 8.39% |
| Earnings Yield | 3.95% |
| FCF Yield | 1.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Atlas Arteria has an Altman Z-Score of 2.16 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.16 |
| Piotroski F-Score | 5 |